Pre-therapy Assessments

Before Beginning Therapy with Immune Checkpoint Inhibitors (ICIs)

Pre-therapy Assessments

^a Prior to initiating treatment, counsel patients and caregivers on the warning signs and symptoms of irAEs.
^b Closer monitoring may be required for patients with combination immunotherapy regimens. Refer to prescribing information for each individual immunotherapy agent for monitoring recommendations.

Connect with us on social

MSD Egypt, 67 – El Tesseen St., Address Building, Fifth Settlement, New Cairo.
In case you need any updates or you have an inquiry or need to report on an adverse reaction, you can contact:

+20226145100

dpoc_egypt@merck.com